PLUS THERAPEUTICS, INC. Earnings Per Share Diluted

Quick Answer

PLUS THERAPEUTICS, INC. reported Earnings Per Share Diluted of $0.29 (loss) per share for the year ending 2025.

  • PLUS THERAPEUTICS, INC. showed an increase of +87.6% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from PLUS THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2009 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2009 to 2025), PLUS THERAPEUTICS, INC.'s Earnings Per Share Diluted has grown by 55.4%.
  • Historical annual values: Fiscal year 2025: $0.29 (loss) per share | Fiscal year 2024: $2.34 (loss) per share | Fiscal year 2023: $4.24 (loss) per share | Fiscal year 2022: $11.58 (loss) per share | Fiscal year 2021: $1.11 (loss) per share | Fiscal year 2011: $0.61 (loss) per share | Fiscal year 2010: $0.60 (loss) per share | Fiscal year 2009: $0.65 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: